News

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

Natco Pharma Limited has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in the Indian Market.

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

NATCO
NATGEN

Upcoming E-conference

Other Related stories

Sai Life Sciences posts 23% revenue growth in Q2 FY27 as EBITDA margin holds at 28%

Cohance Lifesciences Q2 revenue rises 12.9% sequentially; expects stronger H2 growth

Abbott India Q2 FY27 EBITDA Climbs to Rs. 568 Cr

Interviews

Nanotech h

Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma

We aim to

We aim to innovate in India for global markets: Niteen Tulpule, Founder & Director, Orthobiologix Biotech

Targeting

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

Appointments

Glenmark Pharmaceuticals elevates Namita Shah to Sr. VP – Global Portfolio

Glenmark Pharmaceuticals elevates Namita Shah to Sr. VP – Global Portfolio

Zydus appoints Christoph Stoller as President and Business Unit Head, International Markets Business

Zydus appoints Christoph Stoller as President and Business Unit Head, International Markets Business

Alkem appoints Tarundeep Singh Rana as Head – Consumer Business

Alkem appoints Tarundeep Singh Rana as Head – Consumer Business

Startup

Pune health-tech startup clinics on cloud raises $12.5 million as it sets sights on global expansion

Pune health-tech startup clinics on cloud raises $12.5 million as it sets sights on global expansion

StandardX raises £10m to build isotope refinery for cancer care and fusion

StandardX raises £10m to build isotope refinery for cancer care and fusion

C-CAMP National Bio Entrepreneurship competition 2026 recognises 15 startups and four student teams

C-CAMP National Bio Entrepreneurship competition 2026 recognises 15 startups and four student teams

Digitization

Boehringer Ingelheim & Microsoft join forces to explore AI-powered digital patient twins

Boehringer Ingelheim & Microsoft join forces to explore AI-powered digital patient twins

Merck teams up with NVIDIA and Microsoft to build AI-powered support for rare tumor patients

Merck teams up with NVIDIA and Microsoft to build AI-powered support for rare tumor patients

AstraZeneca and Oracle join forces to use AI to accelerate clinical trials, early diagnosis

AstraZeneca and Oracle join forces to use AI to accelerate clinical trials, early diagnosis

Latest Stories

CBC India’s packaging division partners with Indmark Paperform for square fiber drums

Sai Life Sciences posts 23% revenue growth in Q2 FY27 as EBITDA margin holds at 28%

Cohance Lifesciences Q2 revenue rises 12.9% sequentially; expects stronger H2 growth

Alembic Pharma wins USFDA final approval for generic OTC Olopatadine eye drops

Abbott India Q2 FY27 EBITDA Climbs to Rs. 568 Cr

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion

Scientific credibility key to next phase of India's nutraceutical growth: Dr. Saurabh Arora, MD, Auriga Research

Scientific credibility key to next phase of India's nutraceutical growth: Dr. Saurabh Arora, MD, Auriga Research

AI moves from promise to practical impact in public health: Dr. Vikram Niranjan, University of Limerick

AI moves from promise to practical impact in public health: Dr. Vikram Niranjan, University of Limerick

Interviews

Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma

Nanotech has potential to solve fundamental problems of dermatology: Dr. Gabriel Serrano, Founder, Sesderma

Dr. Gabriel Serrano Founder, Sesderma

We aim to innovate in India for global markets: Niteen Tulpule, Founder & Director, Orthobiologix Biotech

We aim to innovate in India for global markets: Niteen Tulpule, Founder & Director, Orthobiologix Biotech

Niteen Tulpule, Founder & Director, Orthobiologix Biotech

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

Targeting Dual PIC/S and EU GMP accreditation to boost global standards: Chirag Doshi, Director, Yesh Medicare

Packaging